Anidulafungin/caspofunginDrug resistance: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1833卷 / 1期

关键词：

D O I：

10.1007/s40278-020-86854-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：36 / 36

相关论文

共 50 条

[41] Cytarabine/etoposide/mitoxantroneSecondary chemo-resistance: 4 case reports
Reactions Weekly, 2019, 1739 (1) : 103 - 103
[42] Cabozantinib/crizotinibDrug resistance and various other toxicities: 4 case reports
Reactions Weekly, 2019, 1740 (1) : 77 - 77
[43] Anidulafungin/caspofunginEosinophilia: case report
Reactions Weekly, 2014, 1532 (1) : 31 - 31
[44] Daptomycin/rifampicin/teicoplaninDevelopment of daptomycin resistance and rifampicin resistance in MRSA infection: 4 case reports
Reactions Weekly, 2016, 1599 (1) : 83 - 83
[45] Anidulafungin/corticosteroids/piperacillin/tazobactumTrichosporon asahii fungaemia and off-label use: 5 case reports
Reactions Weekly, 2021, 1876 (1) : 34 - 34
[46] Adefovir-dipivoxil/entecavir/lamivudine/telbivudineDrug resistance: 4 case reports
Reactions Weekly, 2020, 1817 (1) : 19 - 19
[47] Multiple drugsRelapsing babesiosis, lack of efficacy, antimicrobial resistance: 4 case reports
Reactions Weekly, 2024, 2030 (1) : 356 - 356
[48] AntiretroviralsDrug resistance, virologic rebound and gastrointestinal side effects: 4 case reports
Reactions Weekly, 2020, 1813 (1) : 43 - 43
[49] Amivantamab/erlotinib/patritumab-deruxtecanAcquired drug resistance: 4 case reports
Reactions Weekly, 2023, 1949 (1) : 46 - 46
[50] AntineoplasticsLack of efficacy, acquired drug resistance and infusion reaction: 4 case reports
Reactions Weekly, 2023, 1943 (1) : 85 - 85

← 1 2 3 4 5 →